← Back
Data updated: Mar 29, 2026
ALMAJECT
Infectious DiseaseDermatology
Generics
ALMAJECT is a generic drug manufacturer focused on Infectious Disease, Dermatology.
1987
Since
5
Drugs
-
Trials
72
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (2)
Company Info
- First Approval
- 1987-07-24
- Latest
- 2025-07-09
- Applications
- 7